Has anyone tried Zani? Both Chemos failed me. So next option is Zani has anyone tried it
I'm sorry to hear both chemotherapy regimens stopped working. That's a hard place to be, and it makes sense to look closely at what comes next.
Zani (zanidatamab)
I'm assuming "Zani" means zanidatamab, a drug that has been studied in biliary tract cancers, including cholangiocarcinoma. If you meant something else, tell me and I'll adjust.
Zanidatamab is a bispecific antibody. Unlike trastuzumab (Herceptin), which attaches to one spot on the HER2 protein, zanidatamab attaches to two different spots on HER2 at once. The goal is to block HER2 signaling more completely. It is aimed at cancers that are HER2-positive (also called HER2-amplified or ERBB2-amplified).
Why HER2 status matters
Zanidatamab is a targeted therapy, so it generally only makes sense if your tumor tests positive for HER2 (usually IHC 3+, or IHC 2+ with amplification confirmed by FISH/ISH). Only a minority of biliary tract cancers are HER2-positive, and HER2 appears more often in gallbladder and extrahepatic bile duct cancers than in intrahepatic ones. A tumor that is HER2-negative would not be expected to respond.
What the guidelines and evidence say
- The NCCN Guidelines for Biliary Tract Cancers list HER2-directed therapy among the options for later-line treatment when a tumor has the right molecular features. The NCCN patient guide lists trastuzumab and pertuzumab as examples of targeted therapies for biliary cancers with a HER2 alteration, and the full clinician guidelines are updated more often than the patient version.
- In 2024, the FDA granted accelerated approval to zanidatamab for adults with previously treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer, based on response rates seen in the HERIZON-BTC-01 trial. Accelerated approval means the benefit is still being confirmed in further studies. Please check FDA.gov for the current label, since approvals and indications can change.
On "has anyone tried it?"
Real-world experiences from other patients can be helpful for the human side of treatment, but they can't tell you whether it would work for you, and I can't verify individual reports here. For firsthand accounts, the Cholangiocarcinoma Foundation (cholangiocarcinoma.org) lists patient communities and support groups where people share their treatment experiences. In the trial data, common side effects have included infusion-related reactions and diarrhea, and because HER2-targeted drugs can affect the heart, heart function monitoring is typically part of treatment.
Questions to ask your oncologist
- Has my tumor been tested for HER2, and what was the result (IHC and/or FISH)? If not, can it be tested on my existing tissue or through a blood-based test?
- Has my tumor had full molecular profiling? Other alterations (FGFR2, IDH1, BRAF V600E, NTRK, RET, MSI-H/dMMR) have targeted options too, so it's worth confirming none apply.
- Is zanidatamab approved and covered for my situation, or would I access it through a clinical trial or an expanded access program?
- What side effects should I expect, and what monitoring will I need (for example, heart function tests)?
- If this doesn't work, what are the next options after it?
- Are there clinical trials I should consider alongside or instead of this drug?
Your oncologist will weigh your tumor's molecular results, your overall health, and your prior treatments to decide whether this is the right next step for you.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated November 20, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with general for Cholangiocarcinoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Cholangiocarcinoma
- Is proton therapy an option for Cholangiocarcinoma
- Has anyone had a Targeted test for your bile duct cancer.
- Has anyone had an Intrathecal pain pump implanted
- My Cholangiocarcinoma came back — what are my options now
- Just diagnosed with a rare and very aggressive Cancer (Stage 4) Cholangiocarcinoma. I start chemo Friday March 27th....
- Is there no hope even after surgery it came back. Chemo again. Isn't there something called-ablation
- Hello everyone, I would like to ask if anyone here, or anyone you know, has experience using ivermectin and...
- What are the standard treatment options for cholangiocarcinoma (bile duct cancer)